News | January 07, 2010

Prostate Cancer Research Gets New Funding

January 8, 2010 - The Prostate Cancer Foundation (PCF) will fund at least 10 new Creativity and 20 new multi-year Young Investigator Awards in the first half of 2010 to support innovative research in the field of cancer research.

This new round of funding will support many projects that would otherwise be left unfunded due to cutbacks in federal funding and the global recession.

"We are delighted to announce that we will be funding more than 30 new game-changing research projects in 2010 in addition to the 48 research programs that we are already supporting," commented Jonathan W. Simons, M.D., president, CEO, and David H. Koch, chair of the Prostate Cancer Foundation.

"The commitment of our donors enables us to continue advancing cancer research at a time when other funding sources are shrinking. In 2009, PCF donors contributed more than U.S. $36.5 million-just shy of our 2008 total of $37.2 million-to support PCF's research enterprise. Gifts to the PCF ranged from $5.00 to $5 million. We are grateful to our supporters, both large and small, for making ongoing research progress against prostate cancer possible," they said in a public statement.

PCF funded 10 Creativity Awards in 2009 and 20 Young Investigators in 2008. The foundation will release its list of 2010 Young Investigators in March. The deadline for the Creativity Awards Request for Applications is January 31.

"PCF's Creativity and Young Investigator programs are designed to accelerate scientific research and discovery for funding new treatments and ultimately cures for this disease," commented Howard Soule, Ph.D., PCF's chief science officer responsible for overseeing the foundation's funded research programs. "Traditionally, 70 percent of our Creativity Award recipients go on to earn additional funding for their programs. Our Young Investigators are the human capital bringing new ideas to cancer research. They are energizing the fight against prostate as well as other cancers."

For more information: www.pcf.org

Related Content

ASTRO and ASCO Launch New Cancer Care Quality Registry
News | Radiation Therapy | January 22, 2018
January 22, 2018 — A registry that tracks the quality of medical care provided to patients receiving cancer treatment
First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
Overlay Init